$ARRY ARRAY BIOPHARMA INC Insider Trading Week 30/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARRAY BIOPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARRAY BIOPHARMA INC in week 30/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Sell | D | 48.00 | 24,297 | 1,166,256 | 5,000 | 29.3 K to 5 K (-82.93 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 15.97 | 678,750 | 10,839,638 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 10.92 | 600,000 | 6,552,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 8.79 | 421,875 | 3,708,281 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 3.00 | 453,750 | 1,361,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 7.30 | 113,438 | 828,097 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 4.63 | 345,312 | 1,598,795 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 3.61 | 545,820 | 1,970,410 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | D | 0.00 | 442,190 | 0 | 0 | 442.2 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | D | 48.00 | 259,891 | 12,474,768 | 442,190 | 702.1 K to 442.2 K (-37.02 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 8.70 | 25,000 | 217,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Sell | D | 48.00 | 5,000 | 240,000 | 5,000 | 10 K to 5 K (-50.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 15.97 | 289,500 | 4,623,315 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 10.92 | 289,500 | 3,161,340 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 8.79 | 270,828 | 2,380,578 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 3.00 | 187,500 | 562,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 7.30 | 87,500 | 638,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | D | 0.00 | 114,821 | 0 | 0 | 114.8 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | D | 48.00 | 209,543 | 10,058,064 | 114,821 | 324.4 K to 114.8 K (-64.60 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 15.97 | 138,000 | 2,203,860 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 10.92 | 168,000 | 1,834,560 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 8.79 | 131,250 | 1,153,688 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 3.00 | 82,500 | 247,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 7.30 | 165,000 | 1,204,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Sell | D | 0.00 | 61,813 | 0 | 0 | 61.8 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Sell | D | 48.00 | 150,190 | 7,209,120 | 61,813 | 212 K to 61.8 K (-70.84 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 15.97 | 315,750 | 5,042,528 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 10.92 | 335,250 | 3,660,930 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 8.79 | 313,989 | 2,759,963 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 3.00 | 236,250 | 708,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 7.30 | 236,250 | 1,724,625 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 8.20 | 12,500 | 102,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Sell | D | 0.00 | 130,542 | 0 | 0 | 130.5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Sell | D | 48.00 | 71,022 | 3,409,056 | 130,542 | 201.6 K to 130.5 K (-35.24 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 5.95 | 25,000 | 148,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 5.13 | 25,000 | 128,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 3.87 | 25,000 | 96,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 5.60 | 25,000 | 140,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 4.51 | 20,000 | 90,200 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Sell | D | 48.00 | 15,000 | 720,000 | 5,000 | 20 K to 5 K (-75.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 48.00 | 30,000 | 1,440,000 | 0 | 30 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 15,000 | 720,000 | 30,000 | 45 K to 30 K (-33.33 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 20,000 | 960,000 | 45,000 | 65 K to 45 K (-30.77 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 0.00 | 5,000 | 0 | 65,000 | 70 K to 65 K (-7.14 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 48.00 | 85 | 4,080 | 70,000 | 70.1 K to 70 K (-0.12 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 22,635 | 1,086,480 | 70,085 | 92.7 K to 70.1 K (-24.41 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 15.97 | 157,500 | 2,515,275 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 10.92 | 168,000 | 1,834,560 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 8.79 | 105,302 | 925,605 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 3.77 | 404,450 | 1,524,777 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | D | 0.00 | 56,026 | 0 | 0 | 56 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | D | 48.00 | 30,059 | 1,442,832 | 56,026 | 86.1 K to 56 K (-34.92 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.95 | 25,000 | 148,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.13 | 25,000 | 128,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 3.87 | 25,000 | 96,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.60 | 25,000 | 140,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 4.36 | 20,000 | 87,200 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 2.60 | 20,000 | 52,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Sell | D | 48.00 | 15,000 | 720,000 | 5,000 | 20 K to 5 K (-75.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Option Exercise | D | 14.93 | 25,000 | 373,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Sell | D | 48.00 | 8,000 | 384,000 | 10,000 | 18 K to 10 K (-44.44 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Sell | U | 48.00 | 15,000 | 720,000 | 5,000 | 20 K to 5 K (-75.00 %) |